- Home
- NATH vs ARCT Comparison
NATH vs ARCT Comparison
Compare NATH & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- ARCT
- Stock Information
- Founded
- NATH 1916
- ARCT 2013
- Country
- NATH United States
- ARCT United States
- Employees
- NATH N/A
- ARCT N/A
- Industry
- NATH Restaurants
- ARCT Biotechnology: Pharmaceutical Preparations
- Sector
- NATH Consumer Discretionary
- ARCT Health Care
- Exchange
- NATH Nasdaq
- ARCT Nasdaq
- Market Cap
- NATH 385.4M
- ARCT 444.5M
- IPO Year
- NATH N/A
- ARCT N/A
- Fundamental
- Price
- NATH $93.98
- ARCT $10.53
- Analyst Decision
- NATH
- ARCT Strong Buy
- Analyst Count
- NATH 0
- ARCT 7
- Target Price
- NATH N/A
- ARCT $57.80
- AVG Volume (30 Days)
- NATH 11.0K
- ARCT 462.9K
- Earning Date
- NATH 06-11-2025
- ARCT 05-07-2025
- Dividend Yield
- NATH 2.15%
- ARCT N/A
- EPS Growth
- NATH 24.88
- ARCT N/A
- EPS
- NATH 5.80
- ARCT N/A
- Revenue
- NATH $146,386,000.00
- ARCT $152,310,000.00
- Revenue This Year
- NATH N/A
- ARCT N/A
- Revenue Next Year
- NATH N/A
- ARCT $39.21
- P/E Ratio
- NATH $16.20
- ARCT N/A
- Revenue Growth
- NATH 6.83
- ARCT N/A
- 52 Week Low
- NATH $64.02
- ARCT $8.04
- 52 Week High
- NATH $104.96
- ARCT $45.00
- Technical
- Relative Strength Index (RSI)
- NATH 51.16
- ARCT 43.14
- Support Level
- NATH $92.64
- ARCT $10.07
- Resistance Level
- NATH $95.00
- ARCT $11.00
- Average True Range (ATR)
- NATH 3.33
- ARCT 0.88
- MACD
- NATH 0.06
- ARCT 0.26
- Stochastic Oscillator
- NATH 66.44
- ARCT 77.81
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the research and development segment of medical applications for nucleic acid-focused technology. The company's product pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU and LUNAR-COV19.